Pruritus in cholestasis: Facts and fiction

Hepatology

Volumn 60, Issue 1, 2014, Pages 399-407

  Beuers, Ulrich ^a   Kremer, Andreas E ^a,b   Bolier, Ruth ^a   Elferink, Ronald P J Oude ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROPEROXY 6,8,11,14 ICOSATETRAENOIC ACID; ANION EXCHANGE RESIN; AUTOTAXIN; BILE SALT; CYCLIC AMP DEPENDENT PROTEIN KINASE; FIBROBLAST GROWTH FACTOR 2; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PREGNANE X RECEPTOR; PROTEIN KINASE C; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; URSODEOXYCHOLIC ACID; VANILLOID RECEPTOR 1;

ANTERIOR CINGULATE; ANTINOCICEPTION; CELL ACTIVATION; CELL MIGRATION; CELL SURVIVAL; CHOLESTASIS; CRYSTAL STRUCTURE; DISEASE ASSOCIATION; HUMAN; INTERNEURON; INTRAHEPATIC CHOLESTASIS; MOLECULAR PATHOLOGY; NERVE TRACT; NEUROPATHIC PAIN; NONHUMAN; NONMYELINATED NERVE; PAIN RECEPTOR; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SUPPLEMENTARY MOTOR AREA; UNPLEASANT SENSATION;

CHOLESTASIS; HUMANS; PRURITUS; SIGNAL TRANSDUCTION;

EID: 84903313532     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26909     Document Type: Review

References (36)

1. EASL Clinical Practice Guidelines. Management of cholestatic liver diseases. J Hepatol 2009;51:237-267.
2. Bergasa NV. The itch of liver disease. Semin Cutan Med Surg 2011;30:93-98.
3. Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 2011;35:89-97.
4. McNeil B, Dong X. Peripheral mechanisms of itch. Neurosci Bull 2012;28:100-110.
5. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjork HE. Specific C-receptors for itch in human skin. J Neurosci 1997;17:8003-8008.
6. Yosipovitch G, Ishiuji Y, Patel TS, Hicks MI, Oshiro Y, Kraft RA, et al. The brain processing of scratching. J Invest Dermatol 2008;31:31.
7. Biro T, Toth BI, Marincsak R, Dobrosi N, Geczy T, Paus R. TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta 2007;1772:1004-1021.
8. Nieto-Posadas A, Picazo-Juarez G, Llorente I, Jara-Oseguera A, Morales-Lazaro S, Escalante-Alcalde D, et al. Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site. Nat Chem Biol 2012;8:78-85.
9. Liu Q, Weng HJ, Patel KN, Tang Z, Bai H, Steinhoff M, et al. The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia. Sci Signal 2011;4:ra45.
10. Ross SE, Mardinly AR, McCord AE, Zurawski J, Cohen S, Jung C, et al. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice. Neuron 2010;65:886-898.
11. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448:700-703.
12. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science 2009;325:1531-1534.
13. Mishra SK, Hoon MA. The cells and circuitry for itch responses in mice. Science 2013;340:968-971.
14. Han L, Ma C, Liu Q, Weng HJ, Cui Y, Tang Z, et al. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci 2013;16:174-182.
15. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010;139:1008-1018.
16. Hashimoto T, Ohata H, Momose K. Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology 2004;72:51-56.
17. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002;277:39436-39442.
18. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002;158:227-233.
19. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 2006;281:25822-25830.
20. Nishimasu H, Ishitani R, Aoki J, Nureki O. A 3D view of autotaxin. Trends Pharmacol Sci 2012;33:138-145.
21. van Meeteren LA, Moolenaar WH. Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 2007;46:145-160.
22. Fulkerson Z, Wu T, Sunkara M, Kooi CV, Morris AJ, Smyth SS. Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells. J Biol Chem 2011;286:34654-34663.
23. Kremer AE, van Dijk R, Leckie P, Schaap FG, Kuiper EM, Mettang T, et al. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology 2012;56:1391-1400.
24. Jankowski M. Autotaxin: its role in biology of melanoma cells and as a pharmacological target. Enzyme Res 2011;2011:194857.
25. Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A, Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett 2009;284:216-221.
26. Takeo C, Ikeda K, Horie-Inoue K, Inoue S. Identification of Igf2, Igfbp2 and Enpp2 as estrogen-responsive genes in rat hippocampus. Endocr J 2009;56:113-120.
27. Houben AJ, Moolenaar WH. Autotaxin and LPA receptor signaling in cancer. Cancer Metast Rev 2011;30:557-565.
28. Lisboa LF, Asthana S, Kremer A, Swain M, Bagshaw SM, Gibney N, et al. Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series. Can J Gastroenterol 2012;26:799-805.
29. Choi JW, Chun J. Lysophospholipids and their receptors in the central nervous system. Biochim Biophys Acta 2013;1831:20-32.
30. Alemi F, Kwon E, Poole DP, Lieu T, Lyo V, Cattaruzza F, et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J Clin Invest 2013;123:1513-1530.
31. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992;15:603-608.
32. Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology 1991;101:446-456.
33. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006;3:318-328.
34. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
35. Jones DEJ. Pathogenesis of cholestatic itch: old questions, new answers, and future opportunities. Hepatology 2012;56:1194-1196.
36. Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. Hepatology 2006;44:280-281.